SCP Vitalife Partners
Venture capitalTel Aviv · Seed–Late Stage · 11 people tracked
Also known as SCP VITALIFE MANAGEMENT COMPANY, LLC
Investment thesis
SCP Vitalife invests in life science startups in Israel and the U.S. that develop breakthrough products addressing current medical needs and protected by strong intellectual property. The firm has made more than 30 investments across two funds. Its team consists of professionals with experience as entrepreneurs, senior operating executives, clinical practitioners and technologists, and it provides hands-on support to portfolio companies by leveraging strategic partner relationships to help build successful businesses.
Source: firm website, verified Aug 25, 2026.
Team · 11 people
from the firm's website & public directories
What they invest in
from 11 of 19 portfolio companiesBiotech ×6Healthtech ×6Medical Devices ×6Digital Health ×1EdTech ×1Enterprise Software ×1Media & Entertainment ×1Robotics ×1
HQs:United States×5Israel×2
Investments · 19 tracked
founders shown can be your intro pathBy year:2026 · 12021 · 12020 · 12015 · 32014 · 17 dated
BiotechMarlborough, US
Charles Remsberg(Executive Officer)Larry Jasinski(Executive Officer, Director)Michael Lawless(Executive Officer)Almog Adar(Executive Officer)Jeannine Lynch(Executive Officer)Hadar Levy(Director)
Board seatWayne B. WeismanJeff Dykan· per SEC Form D · $8.8M raise · filed Jul 2020
BiotechHealthtechMedical DevicesWaltham, US
David F. Muller(Executive Officer, Director)inBrian J. Roberts(Executive Officer)inRhonda J. Bracey(Executive Officer)in
BoardJason Hong(Director)Anthony Natale(Director)in
Board seatJeff Dykan· per SEC Form D
Co-investorsAPERTURE Venture PartnersLAVLilly Asia VenturesThird Point VenturesHealthQuest CapitalOrbiMed
Echo360 provides learning engagement and analytics software to educational institutions and organizations.
EdTechEnterprise SoftwareSaaSReston, US
Frederick G.I. Singer(Executive Officer, Director)Anthony Abate(Executive Officer)
BoardJon Patty(Director)Rohit K. Seth(Director)Evan Morgan(Director)Donn Davis(Director)
Board seatWayne B. Weisman· per SEC Form D · $7.5M raise · filed Jan 2016
Co-investorsMultiplier Capitalo15 Capital PartnersRunway Growth CapitalSWaN & Legend Venture PartnersRevolution
Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors.
BiotechHealthtechMedical DevicesAmesbury, US
John Sokolowski(Executive Officer)George W. Gray(Executive Officer)Carolyn Malleck(Executive Officer)Jesse Ambrosina(Executive Officer)
BoardKetan Patel(Director)inJohn K. Clarke(Director)in
Board seatWayne B. Weisman· per SEC Form D
Co-investorsCardinal PartnersF-Prime CapitalECO Fleet Holdings
Specialty biopharmaceutical company developing differentiated prescription drugs for analgesia, anesthesia, sedation, and chronic pain management.
BiotechMalvern, US
Gerri A. Henwood(Executive Officer)
Board seatAbraham LudomirskiWayne B. WeismanWinston J. Churchill· per SEC Form D
Regentis Biomaterials develops regenerative medicine products for tissue repair, focused on orthopedic cartilage and bone treatments through its Gelrin degradable hydrogel platform.
BiotechHealthtechMedical DevicesHerzliya, IL
Galit Reske(Executive Officer)Arie Gordashnikov(Executive Officer)Ori Gon(Executive Officer)
BoardEhud Geller(Executive Officer, Director)Susan Alpert(Director)
Board seatJeff Dykan· per SEC Form D
Applies electro-optic infrared technology for non-contact pharmacological tests including counterfeit drug identification and pharmaceutical quality assurance.
Endospan develops endovascular stent graft systems, including the NEXUS Multi-Branch Aortic Arch Stent Graft System, for repairing aortic aneurysms and dissections in patients whose anatomy is unsuitable for traditional EVAR/TEVAR therapy.
HealthtechMedical Devices
Kevin Mayberry(Chief Executive Officer)Gadi Divald(Chief Financial Officer)
Co-investorsAccelmed Partners
Cell therapy company focused on dermal-based regenerative therapy with proprietary scalable cell-manufacturing technology.
Biopharmaceutical company developing novel therapeutics for neurological diseases, initially targeting Parkinson's disease with potential disease modification.
Modern Systems Talk (MST) publishes content and insights on technology topics including system architecture, cloud computing, automation, AI, cybersecurity, and digital transformation.
Media & Entertainment
Co-investorsAgate Medical Investments LP
Commercializing CE-marked and FDA-cleared surgical devices for gastro-intestinal surgery using Nitinol-based products for natural tissue closure.
Developed an innovative automated clinical in-vitro diagnostic system providing real-time pathogen detection and identification without reagents.
BiotechRehovot
Ellen Cunniff(Executive Officer)Jonathan Gurfinkel(Executive Officer, Director)Eduard J. Ludwig(Director)Meir Hadar(Director)Gal Ingber(Executive Officer)Zvika Blutstein(Executive Officer)
Lifeward (ReWalk) develops wearable exoskeletons and related products for physical rehabilitation and recovery, used in conditions such as spinal cord injury, brain injury, stroke, multiple sclerosis, and orthopedic/sports medicine.
HealthtechMedical DevicesRobotics
Co-investorsPontifax Venture Capital
Developing a non-invasive device for monitoring congestive heart failure through continuous measurement of pulmonary congestion parameters.
Developing a technology platform for orthopedics featuring a minimally invasive, motion-preserving interspinous spacer to treat low back and leg pain.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
IPOs and acquisitions across the tracked portfolioPortfolio news
latest coverage across their companiesLifeward · stocktitan.net · Aug 14, 2026
MST · pluang.com · Aug 10, 2026
Endospan · massdevice.com · May 12, 2026
Ivenix · trysignalbase.com · Mar 25, 2026
Echo 360 · marketbrief.edweek.org · May 22, 2025
Fund performance · per public LP disclosures · 3
as of Dec 2024| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| SCP Vitalife Partners II FundLPs: New York City Employees' Retirement System, New York City Police Pension Fund, New York City Fire Department Pension Fund | 2007 | — | -14.2% | 0.14x | 0.00x |
| SCP Vitalife Partners II, L.P.LPs: New York City Police Pension Fund, Teachers' Retirement System of the City of New York | 2007 | — | -17.7% | 0.07x | 0.07x |
| SCP Vitalife Partners Il FundLPs: New York City Fire Department Pension Fund | 2007 | — | -14.0% | 0.14x | 0.00x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- How many investments has SCP Vitalife Partners made?
- SCP Vitalife Partners has 17 tracked investments, 1 of which have exited via acquisition or IPO, including 1 dated in the last 24 months.
- What stage does SCP Vitalife Partners invest at?
- SCP Vitalife Partners invests at the Seed, Series A, Series B, Late Stage stages.
- What is SCP Vitalife Partners's typical check size?
- SCP Vitalife Partners typically writes checks of $3M – $7M.
- What sectors does SCP Vitalife Partners focus on?
- SCP Vitalife Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is SCP Vitalife Partners located?
- SCP Vitalife Partners is headquartered in Tel Aviv, IL.
- Who does SCP Vitalife Partners co-invest with?
- SCP Vitalife Partners most often shares deals with APERTURE Venture Partners, Cardinal Partners, F-Prime Capital, among 9 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.